Clinical trial
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
NCT00433862 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00433862 |
|---|---|
| Title | Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders |
| Official title | Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Polycythemia Vera, Essential Thrombocytosis, Idiopathic Myelofibrosis, Neutrophils, Chronic Myeloproliferative Disorders |
| Enrollment | 8 |
| Start date | Feb 6, 2007 |
| Completion | May 19, 2010 |
| First posted | Feb 12, 2007 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: